首页> 外文期刊>World Journal of Gastroenterology >Generation of human/rat xenograft animal model for the study of human donor stem cell behaviors in vivo
【24h】

Generation of human/rat xenograft animal model for the study of human donor stem cell behaviors in vivo

机译:用于研究人类供体干细胞在体内行为的人类/大鼠异种移植动物模型的生成

获取原文
获取原文并翻译 | 示例
       

摘要

AIM: To accurately and realistically elucidate human stem cell behaviors in vivo and the fundamental mechanisms controlling human stem cell fates in vivo, which is urgently required in regenerative medicine and treatments for some human diseases, a surrogate human-rat chimera model was developed. METHODS: Human-rat chimeras were achieved by in utero transplanting low-density mononuclear cells from human umbilical cord blood into the fetal rats at 9-11 d of gestation, and subsequently, a variety of methods, including flow cytometry, PCR as well as immunohistochemical assay, were used to test the human donor contribution in the recipients. RESULTS: Of 29 live-born recipients, 19 had the presence of human CD45~+ cells in peripheral blood (PB) detected by flow cytometry, while PCR analysis on genomic DNA from 11 different adult tissues showed that 14 selected from flow cytometry-positive 19 animals possessed of donor-derived human cell engraftment in multiple tissues (i.e. liver, spleen, thymus, heart, kidney, blood, lung, muscle, gut and skin) examined at the time of tissue collection, as confirmed by detecting human β2-microglobulin expression using immunohistochemistry. In this xenogeneic system, the engrafted donor-derived human cells persisted in multiple tissues for at least 6 mo after birth. Moreover, transplanted human donor cells underwent site-specific differentiation into CK18-positive human cells in chimeric liver and CD45-positive human cells in chimeric spleen and thymus of recipients. CONCLUSION: Taken together, these findings suggest that we successfully developed human-rat chimeras, in which xenogeneic human cells exist up to 6 mo later. This humanized small animal model, which offers an in vivo environment more closely resembling to the situations in human, provides an invaluable and effective approach for in vivo investigating human stem cell behaviors, and further in vivo examining fundamental mechanisms controlling human stem cell fates in the future. The potential for new advances in our better understanding the living biological systems in human provided by investigators in humanized animals will remain promising.
机译:目的:为了准确,现实地阐明体内人类干细胞的行为以及体内控制人类干细胞命运的基本机制,这在再生医学和某些人类疾病的治疗中迫切需要,因此开发了一种替代人类-大鼠嵌合体模型。方法:人-鼠嵌合体是通过在妊娠9-11天时子宫内将脐带血中的低密度单核细胞移植到胎儿大鼠中而获得的,随后采用了多种方法,包括流式细胞术,PCR和免疫组织化学分析法用于测试人类捐赠者在受者中的贡献。结果:在29名活产受体中,有19名通过流式细胞仪检测到外周血(PB)中存在人CD45〜+细胞,而对11种不同成人组织的基因组DNA的PCR分析表明,有14种选自流式细胞仪阳性通过检测人类β2-β2证实,在收集组织时检查了19种动物,它们在多个组织(即肝,脾,胸腺,心脏,肾脏,血液,肺,肌肉,肠和皮肤)中具有供体来源的人类细胞移植。微球蛋白的表达采用免疫组织化学。在这种异种系统中,移植的供体来源的人类细胞出生后在多个组织中持续存在至少6 mo。此外,移植的人类供体细胞经过位点特异性分化为嵌合肝脏中的CK18阳性人类细胞和受体嵌合脾和胸腺中的CD45阳性人类细胞。结论:综上所述,这些发现表明我们成功开发了人类-大鼠嵌合体,其中异种人类细胞存在至6mo。这种人源化的小动物模型提供了一种更类似于人类情况的体内环境,为体内研究人类干细胞行为,并进一步体内研究控制人类干细胞命运的基本机制提供了一种宝贵而有效的方法。未来。研究人员对人源化动物所提供的更好的理解人类活生物系统的新进展的潜力仍然是有希望的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号